WO2005017176A3 - Methods for identifying risk of melanoma and treatments thereof - Google Patents

Methods for identifying risk of melanoma and treatments thereof Download PDF

Info

Publication number
WO2005017176A3
WO2005017176A3 PCT/US2004/014238 US2004014238W WO2005017176A3 WO 2005017176 A3 WO2005017176 A3 WO 2005017176A3 US 2004014238 W US2004014238 W US 2004014238W WO 2005017176 A3 WO2005017176 A3 WO 2005017176A3
Authority
WO
WIPO (PCT)
Prior art keywords
melanoma
methods
risk
treatments
fpgt
Prior art date
Application number
PCT/US2004/014238
Other languages
French (fr)
Other versions
WO2005017176A2 (en
Inventor
Richard B Roth
Matthew Roberts Nelson
Stefan M Kammerer
Andreas Braun
Carolyn R Hoyal-Wrightson
Original Assignee
Sequenom Inc
Richard B Roth
Matthew Roberts Nelson
Stefan M Kammerer
Andreas Braun
Carolyn R Hoyal-Wrightson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/703,817 external-priority patent/US20050118117A1/en
Application filed by Sequenom Inc, Richard B Roth, Matthew Roberts Nelson, Stefan M Kammerer, Andreas Braun, Carolyn R Hoyal-Wrightson filed Critical Sequenom Inc
Publication of WO2005017176A2 publication Critical patent/WO2005017176A2/en
Publication of WO2005017176A3 publication Critical patent/WO2005017176A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more NRP1, NID2, ENDO180, CDK10, FPGT, CARD PCLO or REPS2 directed agents. These embodiments are based upon an analysis of polymorphic variations in a NRPI, NID2, ENDO180, CDK10, FPGT, CARK, PCLO or REPS2 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1-17.
PCT/US2004/014238 2003-07-23 2004-05-05 Methods for identifying risk of melanoma and treatments thereof WO2005017176A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US48970303P 2003-07-23 2003-07-23
US60/489,703 2003-07-23
US10/703,817 US20050118117A1 (en) 2002-11-06 2003-11-06 Methods for identifying risk of melanoma and treatments thereof
US10/703,817 2003-11-06
US10/704,513 US20050170500A1 (en) 2002-11-06 2003-11-06 Methods for identifying risk of melanoma and treatments thereof
US10/704,513 2003-11-06
US10/703,789 US20050064440A1 (en) 2002-11-06 2003-11-06 Methods for identifying risk of melanoma and treatments thereof
US10/703,789 2003-11-06

Publications (2)

Publication Number Publication Date
WO2005017176A2 WO2005017176A2 (en) 2005-02-24
WO2005017176A3 true WO2005017176A3 (en) 2007-10-04

Family

ID=34199243

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/014238 WO2005017176A2 (en) 2003-07-23 2004-05-05 Methods for identifying risk of melanoma and treatments thereof

Country Status (1)

Country Link
WO (1) WO2005017176A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1905825A1 (en) * 2006-09-29 2008-04-02 greenovation Biotech GmbH Galactosyltransferase
JP6892695B2 (en) * 2016-11-30 2021-06-23 国立大学法人秋田大学 Human Genome DNA Detection Method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KROESE ET AL., GENETICS IN MEDICINE, vol. 6, 2004, pages 475 - 480, XP008061434 *
LUCENTINI, THE SCIENTIST, vol. 18, 2004, pages 20, XP002985230 *

Also Published As

Publication number Publication date
WO2005017176A2 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
WO2004044164A3 (en) Method for identifying risk of melanoma and treatments thereof
ATE437962T1 (en) METHOD FOR THE TREATMENT OF PROLIFERATIVE DISEASES OF BREAST CELLS
DE60045796D1 (en) TOTAL CHROMOSOME ANALYSIS OF PROTEIN-DNS INTERACTIONS
WO2004047514A3 (en) Methods for identifying risk of breast cancer and treatments thereof
MXPA02012743A (en) Il-17 molecules and uses thereof.
WO2002092818A8 (en) Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
EP1151140A4 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO2005027710A3 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
WO2005014846A3 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2005001141A3 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
WO2003078603A3 (en) Strong gene sets for glioma classification
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof
WO2005017176A3 (en) Methods for identifying risk of melanoma and treatments thereof
WO2005001140A3 (en) Methods and nucleic acids for the analysis of colon cell proliferative disorders
WO2004048546A3 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2004048548A3 (en) Methods for identifying risk of breast cancer and treatments thereof
ATE350489T1 (en) DIAGNOSIS OF DISEASES ASSOCIATED WITH HUMOS
EP1662006A4 (en) Partially double stranded nucleic acid molecule
WO2005118834A3 (en) Methods for identifying risk of breast cancer and treatment thereof
WO2006074061A3 (en) Methods for identifying risk of low bmd and treatments thereof
WO2001020030A3 (en) Nucleotide sequences derived from genes coding for trimethylamine n-oxide reductase, uses thereof in particular for detecting bacteria
WO2006063285A3 (en) Methods for identifying risk of breast cancer or prostate cancer and treatments thereof
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
AU2001226785A1 (en) Method, kit and dna probes for detecting a fungal species in clinical material
DE69940848D1 (en) (-) - STRING RNA VIRUS VECTOR FOR NERVE CELLS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase